8-K

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 8-K


                Current Report Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934



       Date of Report (Date of earliest event reported): February 13, 2007


                        Blonder Tongue Laboratories, Inc.
             (Exact Name of registrant as specified in its charter)



           Delaware                      1-14120                   52-1611421
(State or other jurisdiction      (Commission File Number)      (I.R.S. Employer
      of incorporation)                                       Identification No.)


                One Jake Brown Road, Old Bridge, New Jersey 08857
               (Address of principal executive offices) (Zip Code)



       Registrant's telephone number, including area code: (732) 679-4000


                                 Not Applicable
          (Former name or former address, if changed since last report)


Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:


[_]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR 230.425)


[_]  Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)


[_]  Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
     Exchange Act (17 CFR 240.14d-2(b))


[_]  Pre-commencement   communications  pursuant  to  Rule  13e-4(c)  under  the
     Exchange Act (17 CFR 240.13e-4(c))








ITEM 7.01.  REGULATION FD DISCLOSURE.

On February 13, 2007, Blonder Tongue Laboratories, Inc. (the "Company") issued a
press  release  announcing  its  Board  of  Directors  authorized  a  new  stock
repurchase program.  The press release is attached hereto as Exhibit 99.1 and is
incorporated into this Item 7.01 by reference.

ITEM 8.01.  OTHER EVENTS.

On February  13, 2007,  the Company  announced  that its Board of Directors  has
authorized a new stock repurchase program to acquire up to 100,000 shares of its
outstanding  common stock.  This  authorization  supplements  the existing stock
repurchase  plan adopted in July 2002,  under which the Company may still expend
approximately  $100,000 to acquire  additional  shares of its common stock.  The
Company  intends to resume making  purchases  under the July 2002 plan up to its
limits,  and thereafter to make  purchases  under the new 100,000 share program.
Purchases  will be funded from  available  working  capital and the  repurchased
shares may be  retired  or may be held in  treasury  or used for  ongoing  stock
issuance such as for employee stock plans.


ITEM 9.01.  FINANCIAL STATEMENTS AND EXHIBITS.

(d)      Exhibits.

Exhibit Number             Description
Exhibit 99.1           Press Release of Blonder Tongue Laboratories, Inc.
                       issued February 13, 2007








                                    SIGNATURE


Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


                                    BLONDER TONGUE LABORATORIES, INC.


                                    By:/s/ Eric Skolnik                                    
                                         Eric Skolnik
                                         Senior Vice President
                                         and Chief Financial Officer

Date: February 13, 2007





                                       3



                                  EXHIBIT INDEX

Exhibit Number             Description
Exhibit 99.1            Press Release of Blonder Tongue Laboratories, Inc.
                        issued February 13, 2007




                                       4

EX-99

[LOGO]


                                                             One Jake Brown Road
                                               Old Bridge, New Jersey 08857-1000
                                           Tel: 732-679-4000   Fax: 732-679-4353
                                                           www.blondertongue.com


   FOR IMMEDIATE RELEASE                   CONTACT:      James A. Luksch
                                                         Chairman and
                                                         Chief Executive Officer
                                                         (732) 679-4000



         BLONDER TONGUE ANNOUNCES 100,000 SHARE STOCK REPURCHASE PROGRAM

OLD BRIDGE, NEW JERSEY,  February 13, 2007 - Blonder Tongue  Laboratories,  Inc.
(AMEX:  "BDR")  announced today that its Board of Directors has authorized a new
stock  repurchase  program to acquire  up to 100,000  shares of its  outstanding
common stock. The program is intended to be implemented  through  purchases made
from time to time in the open market or through block trades.

This  authorization  supplements  the existing stock  repurchase plan adopted in
July 2002, under which Blonder Tongue may still expend approximately $100,000 to
acquire  additional  shares of its common stock.  The Company  intends to resume
making  purchases  under the July 2002 plan up to its limits,  and thereafter to
make  purchases  under the new 100,000  share  program.  As of January 31, 2007,
6,222,252 shares of the Company's common stock were outstanding.

Depending  on  market  conditions  and other  factors,  these  purchases  may be
commenced or suspended  at any time or from time to time without  prior  notice.
Purchases  will be funded from  available  working  capital and the  repurchased
shares may be  retired  or may be held in  treasury  or used for  ongoing  stock
issuance such as for employee stock plans.

"Approval  of this  program  reflects  a strong  belief by our Board in  Blonder
Tongue's future.  We believe the current valuation of our stock does not reflect
the underlying  long-term value of the Company.  We continue to believe that the
purchase of our common stock at the current stock price represents an attractive
opportunity  to  benefit  the  long-term   interests  of  the  Company  and  its
shareholders,"  said James A. Luksch,  Chairman of the Board and Chief Executive
Officer.

Founded  in  1950,  Blonder  Tongue  Laboratories,   Inc.  has  evolved  from  a
manufacturer  of  electronic  equipment  for the  private  cable  industry  to a
principal  provider of integrated  network  solutions and technical  services to
broadband service providers. The Company designs,  manufactures,  and supplies a
comprehensive line of equipment to deliver video (analog & digital),  high speed
data and voice  services  over  integrated  coaxial  and fiber  optic  broadband
networks today and over packet based,  Internet protocol networks of the future.
For more information regarding Blonder Tongue or its products,  please visit the
Company's Web site at  www.blondertongue.com  or contact the Company directly at
(732) 679-4000.

"Safe Harbor"  Statement under the Private  Securities  Litigation Reform Act of
1995: The information set forth above includes "forward-looking"  statements and
accordingly,  the cautionary  statements  contained in Blonder  Tongue's  Annual
Report and Form 10-K for the year ended December 31, 2005 (See Item 1: Business,
Item 1A:  Risk  Factors  and Item 7:  Management's  Discussion  and  Analysis of
Financial  Condition  and Results of  Operations),  and other  filings  with the
Securities and Exchange  Commission (such as Blonder Tongue's  Quarterly Reports
on Form  10-Q) are  incorporated  herein  by  reference.  The  words  "believe",
"expect",  "anticipate",  "should",  "project", and similar expressions identify
forward-looking statements. Readers are cautioned not to place undue reliance on
these forward-looking statements, which reflect management's analysis only as of
the date hereof. There can be no assurance that Blonder Tongue will purchase any
shares under the stock  repurchase  program or that such  purchases will enhance
the financial results of the company in the future. Blonder Tongue undertakes no
obligation to publicly revise these forward-looking statements to reflect events
or  circumstances  that arise after the date  hereof.  Blonder  Tongue's  actual
results may differ from the anticipated results or other expectations  expressed
in Blonder Tongue's "forward-looking" statements.